DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Amplifi Vascular, Inc.
Amplifi Vascular, Inc.
Series APrairie Village, KSBiotechnology
Facts
Financing history
3 rounds
- Oct 9, 2025Series A · $6.8M (disclosed)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval”
- Aug 21, 2024Form D equity offering · $6.0M (form d sold) · 59 investorsFact SEC EDGAR Form D data sets (quarterly) · “Amplifi Vascular, Inc. filed Form D/A: $5,960,278 sold of $12,000,000, Biotechnology”
- Jul 28, 2023Form D equity offering · $808,000 (form d sold) · 6 investorsFact SEC EDGAR Form D data sets (quarterly) · “Amplifi Vascular, Inc. filed Form D/A: $808,000 sold of $8,000,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
1 officers, 3 directors
- Sean Morris Executive Officer/Director sec.gov
- Nathaniel Hagedorn Director Fact
- James Schultz Director Fact
- Steve Braun Director Fact
Timeline
5
- Jun 30, 2026Amplifi Vascular, Inc. filed Form D/A: $5,960,278 sold of $12,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Mar 26, 2026Amplifi Vascular, Inc. filed Form D/A: $5,910,278 sold of $6,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Oct 9, 2025Amplifi Vascular announced Series A of $6,800,000Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
- Nov 27, 2024Amplifi Vascular, Inc. filed Form D: $1,543,619 sold of $4,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Jun 25, 2024Amplifi Vascular, Inc. filed Form D/A: $808,000 sold of $8,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
61 observations
Every observation on this company
- Entity type: Corporation Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $6.0M Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $5.9M Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $1.5M Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $808,000 Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $12.0M Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $6.0M Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $4.0M Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $8.0M Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-08-21 Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-08-21 Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-08-21 Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2023-07-28 Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 59 Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 59 Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 23 Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 6 Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: debt,option Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: debt,option Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: debt,option Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 3965 West 83rd Street, #300, Prairie Village, KS, 66208 Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 3965 West 83rd Street, #300, Prairie Village, KS, 66208 Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 3965 West 83rd Street, #300, Prairie Village, KS, 66208 Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON, DE, 19801 Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Round announced: Series A $6,800,000 Oct 9, 2025 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
- Year of incorporation: 2023 Jun 30, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2023 Mar 26, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2023 Nov 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2023 Jun 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)